Patent details

EP1294391 Title: COMBINATION OF AGENTS FOR INHIBITING TRANSPLANT REJECTION

Basic Information

Publication number:
EP1294391
PCT Application Number:
PCT/US/2001/018619
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019421189
PCT Publication Number:
WO/2001/095928
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF AGENTS FOR INHIBITING TRANSPLANT REJECTION
French Title of Invention:
COMBINAISONS D'AGENTS POUR EVITER LE REJET DE GREFFE
German Title of Invention:
WIRKSTOFFKOMBINATION ZUR VERHINDERUNG DER TRANSPLANTATABSTOSSUNG
SPC Number:

Dates

Filing date:
08/06/2001
Grant date:
15/08/2012
EP Publication Date:
15/08/2012
PCT Publication Date:
20/12/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/03/2003
EP B1 Publication Date:
15/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/06/2013
Expiration date:
08/06/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/06/2001
 
 

Name:
Bristol-Myers Squibb Company
Address:
Lawrenceville-Princeton Road P.O. Box 4000, Princeton NJ 08543-4000, United States (US)

Inventor

1

Name:
PEACH Robert, J.
Address:
United States (US)

2

Name:
TODDERUD Charles, Gordon
Address:
United States (US)

3

Name:
TOWNSEND Robert, M.
Address:
United States (US)

Priority

Priority Number:
210671 P
Priority Date:
09/06/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/17;
Filing date Document type Number of pages